ArticleDiscover oncology2023

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma.

Youshi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.